Advanced search
Publication Cover
Leukemia & Lymphoma Volume 42, 2001 - Issue 3
Submit an article Journal homepage
18
Views
0
CrossRef citations to date
0
Altmetric
Original Article

CAM-Cytarabine, Aclarubicin Plus Macrophage Colony-Stimulating Factor in the Treatment of Acute Myelogenous Leukemia with Trilineage Dysplasia: Usefulness of in Vitro Apoptosis in Leukemic Cells

Masaki Mori Department of Hematolog, Jichi Medical School, 3311-1 Yakushiji, Minamikawachi, Kawachi, Tochigi, 329-0498, Japan
,
Kiyohiko Hatake Department of Hematolog, Jichi Medical School, 3311-1 Yakushiji, Minamikawachi, Kawachi, Tochigi, 329-0498, Japan; Department of Medical Oncology, Cancer Institute Hospital, at Japanese Foundation for Cancer Research, 1–37–1 Kami-Ikebukuro, Toshima-ku, Tokyo, 170-8455, JapanCorrespondence[email protected]
,
Masaru Tanaka Department of Hematolog, Jichi Medical School, 3311-1 Yakushiji, Minamikawachi, Kawachi, Tochigi, 329-0498, Japan
,
Masaaki Takatoku Department of Hematolog, Jichi Medical School, 3311-1 Yakushiji, Minamikawachi, Kawachi, Tochigi, 329-0498, Japan
,
Yuko Matsumoto Department of Hematolog, Jichi Medical School, 3311-1 Yakushiji, Minamikawachi, Kawachi, Tochigi, 329-0498, Japan
,
Mie Ucjhida Department of Hematolog, Jichi Medical School, 3311-1 Yakushiji, Minamikawachi, Kawachi, Tochigi, 329-0498, Japan
,
Minako Kametaka Department of Hematolog, Jichi Medical School, 3311-1 Yakushiji, Minamikawachi, Kawachi, Tochigi, 329-0498, Japan
,
Tadashi Nagai Department of Hematolog, Jichi Medical School, 3311-1 Yakushiji, Minamikawachi, Kawachi, Tochigi, 329-0498, Japan
,
Yasuhito Terui Department of Hematolog, Jichi Medical School, 3311-1 Yakushiji, Minamikawachi, Kawachi, Tochigi, 329-0498, Japan
,
Hiroshi Tomeuka Department of Hematolog, Jichi Medical School, 3311-1 Yakushiji, Minamikawachi, Kawachi, Tochigi, 329-0498, Japan
,
Kazuo Muroi Department of Hematolog, Jichi Medical School, 3311-1 Yakushiji, Minamikawachi, Kawachi, Tochigi, 329-0498, Japan
&
Keiya Ozawa Department of Hematolog, Jichi Medical School, 3311-1 Yakushiji, Minamikawachi, Kawachi, Tochigi, 329-0498, Japan
 show all
Pages 387-391 | Received 01 Dec 2000, Published online: 01 Jul 2009

References

  • Brito-Babapulle F., Catovsky D., Gallon D. Clinical and laboratory features of de novo acute leukemia with trilineag myelodysplasia. British Journal of Haematology 1987; 66: 445–450
  • Jinnai I., Tomonaga M., Kuriyama M., Matsuo T., Nonaka H., Amenomori T., Yoshida Y., Kusano M., Tagawa M., Ichimaru M. Dysmegakaryocytosis in acute leukaemias: its predominance in myelo-monocytotic (M4) leukaemia and implication for poor response to chemotherapy. British Journal of Haematology 1987; 66: 467–472
  • Kuriyama K., Tomonaga M., Matsuo T., Kobayashi T., Miwa H., Shirakawa S., Tanimoto M., Adachi K., Emi N., Hiraoka A. Poor response to intensive chemotherapy in de novo acute myeloid leukemia with trilineage myelodysplasia. Japan Adult Leukemia Study Group (JALSG). British Journal of Haematology 1994; 86: 767–773
  • Yamada K., Furusawa S., Saito K., Waga K., Koike T., Arimura H., Aoyagi A., Yamato H., Sakuma H., Tsunogake S., Yoshida M., Aoyagi M., Nakamura Y., Enokihara H., Tanaka K., Nakazawa K., Shishido H. Concurrent use of granulocyte colony-stimulating factor with low-dose cytosine arabinoside and aclarubicin for previously treated acute myelogenous leukemia: a pilot study. Leukemia 1995; 9: 10–14
  • Becker S., Warren M. K., Haskill S. Colony-stimulating factor-induced monocyte survival and differentiation into macrophages in serum-free cultures. Journal of Immunology 1987; 139: 3703–3709
  • Ikeda T., Sasaki K., Ikeda K., Yamaoka G., Kawanishi K., Kawachi Y., Uchida T., Takahara J., Irino S. A new cytokine-dependent monoblastic cell line with t(9;11)(p22;q23) differentiates to macrophages with macrophage colony-stimulating factor (M-CSF) and to osteoclast-like cells with M-CSF and interleukin-4. Blood 1998; 91: 4543–4553
  • Kitano K., Kobayashi H., Maeyama H., Miyabayashi H., Furuta S. Treatment of acute monoblastic leukaemia by combination of recombinant human macrophage colony-stimulating factor and low dose ara-C. British Journal of Haematology 1993; 85: 176–178
  • Murayama T., Imoto S., Nakazuka T., Chihara K., Matsui T. Proliferative reaction of myelogenous leukemia cells with cytokines G-CSF, GM-CSF, M-CSF, SCF and, TPO. Leukemia Research 1998; 22: 557–560
  • Motoyoshi K., Takaku F., Mizoguchi H., Miura Y. Purification and some properties of colony-stimulating factor from normal human urine. Blood 1978; 52: 1012–1020
  • Motoyoshi K. Biological activities and clinical application of M-CSF. International Journal of Hematology 1998; 67: 109–122
  • Suzu S., Yokota H., Yamada M., Yanai N., Motoyoshi K. Enhancing effects of human monocytic colony-stimulating factor on monocyte tumoricidal activity. Cancer Research 1989; 49: 5913–5917
  • Douzono M., Suzu S., Yamada M., Yanai N., Hatake K., Motoyoshi K. Augmentation of cancer chemotherapy by preinjection of human macrophage colony-stimulating factor in L1210 leukemic cell-inoculated mice. Japanese Journal of Cancer Research 1995; 86: 315–321
  • Kreutz M., Fritsche J., Ackermann U., Krause S. W., Andreesen R. Retinoic acid inhibits monocyte to macrophage survival and differentiation. Blood 1998; 91: 4796–4802
  • Ohno R., Miyawaki S., Hatake K., Kuriyama K., Saito K., Kanamaru A., Kobayashi T., Kodera Y., Nishikawa K., Matsuda S., Yamada O., Omoto E., Takeyama H., Tsukuda K., Asou N., Tanimoyo M., Shiozaki H., Tomonaga M., Masaoka T., Miura Y., Takaku F., Ohashi Y., Motoyoshi K. Human urinary macrophage colony-stimulating factor reduces the incidence and duration of febrile neutropenia and shortens the period required to finish three courses of intensive consolidation therapy in acute myeloid leukemia: a double-blind controlled study. Journal of Clinical Oncology 1997; 15: 2954–2965
  • Hatake K., Izumi T., Imagawa S., Ohta M., Miura Y. Macrophage colony-stimulating factor and platelet recovery after chemotherapy. Lancet 1993; 341: 963
  • Kaito K., Kobayashi M., Sakamoto M., Shimada T., Matsuoka H., Nishiwaki K. I., Saeki A., Sekita K., Otsubo H., Hosoya T. Combination chemotherapy with G-CSF, M-CSF and EPO: successful treatment for acute myelogenous leukaemia without blood transfusion at lower medical costs. Acta Haematologica 1998; 100: 57–60

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.